Back to News
Market Impact: 0.15
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc.
Source: prnewswire.com
Legal & LitigationHealthcare & Biotech
Pomerantz LLP said it is investigating claims on behalf of investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD). The notice provides contact information for investors but does not specify the claims or alleged conduct.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.10
Ticker Sentiment
ACAD-0.65
More News
- We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
- ATEC Q3 2026 slides show profitability surge despite execution gaps
- West Pharma earnings show it's more than a GLP-1 play. Why we see more upside
- Utah charges Kalshi's founders, escalating a war over who can regulate prediction markets
- Aspen Neuroscience prices IPO at $15 per share
- Linde delivers a good quarter and puts in a fix for an overhang on the stock